| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10042516 | HBV | ENSG00000197993.9 | protein_coding | KEL | Yes | No | 3792 | A0A077QP03 P23276 |
| TVIS44009878 | HTLV-1 | ENSG00000197993.9 | protein_coding | KEL | Yes | No | 3792 | A0A077QP03 P23276 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | KEL |
|---|---|
| DrugBank ID | DB02557 |
| Drug Name | Phosphoramidon |
| Target ID | BE0008984 |
| UniProt ID | P23276 |
| Regulation Type | |
| PubMed IDs | 15769748 |
| Citations | Claperon A, Rose C, Gane P, Collec E, Bertrand O, Ouimet T: The Kell protein of the common K2 phenotype is a catalytically active metalloprotease, whereas the rare Kell K1 antigen is inactive. Identification of novel substrates for the Kell protein. J Biol Chem. 2005 Jun 3;280(22):21272-83. Epub 2005 Mar 15. |
| Groups | Experimental |
| Direct Classification | Dipeptides |
| SMILES | CC(C)C[C@H](NP(O)(=O)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL479579 |
